In today’s recent session, 0.45 million shares of the Oncolytics Biotech, Inc (NASDAQ:ONCY) have been traded, and its beta is 0.77. Most recently the company’s share price was $0.64, and it changed around $0.0 or -0.14% from the last close, which brings the market valuation of the company to $56.81M. ONCY at last check was trading at a discount to its 52-week high of $1.53, offering almost -139.06% off that amount. The share price’s 52-week low was $0.33, which indicates that the recent value has risen by an impressive 48.44% since then.

Oncolytics Biotech, Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.40. If we narrow it down even further, the data shows that 0 out of 6 analysts rate the stock as a Sell; another 4 rate it as Overweight. Among the rest, 1 recommended ONCY as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight.

Oncolytics Biotech, Inc (NASDAQ:ONCY) trade information

Instantly ONCY has been showing red trend so far today with a performance of -0.14% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.6661 on recent trading dayincreased the stock’s daily price by 3.92%. The company’s shares are currently down -30.01% year-to-date, but still up 49.79% over the last five days. On the other hand, Oncolytics Biotech, Inc (NASDAQ:ONCY) is 36.78% up in the 30-day period.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 23.13%. Oncolytics Biotech, Inc earnings are expected to increase by 4.14% in 2025, but the outlook is positive 6.60% per year for the next five years.

ONCY Dividends

Oncolytics Biotech, Inc’s next quarterly earnings report is expected to be released in July.

SEEDS INVESTOR LLC, with 0.2496% or 0.19 million shares worth $0.19 million as of 2024-06-30, holds the second largest percentage of outstanding shares.